Some finding from the WWW on IVERMECTIN
Ivermectin has used to treat a variety of internal nematode infections, including Onchocerciasis, Strongyloidiasis, Ascariasis, cutaneous larva migrans, filariases, Gnathostomiasis and Trichuriasis, as well as for oral treatment of ectoparasitic infections, such as Pediculosis (lice infestation) and scabies (mite infestation).
14) Ivermectin is the essential mainstay of two global disease elimination campaigns that should soon rid the world of two of its most disfiguring and devastating diseases, Onchocerciasis and Lymphatic filariasis, which blight the lives of billions of the poor and disadvantaged throughout the tropics. It is likely that, throughout the next decade, well over
Hundreds of MILLIONS of people will be taking the drug annually or semi-annually,
via innovative globally-coordinated Mass Drug Administration (MDA) programmes. Indeed, the discovery, development and deployment of ivermectin, produced by an unprecedented partnership between the Private Sector pharmaceutical multinational Merck & Co. Inc., and the Public Sector Kitasato Institute in Tokyo, aided by an extraordinary coalition has been recognized by many experts and observers as one of the greatest medical accomplishments of the 20th century
Approved for human use in 1987, today it is used to treat infestations including
head lice,
scabies,
river blindness (onchocerciasis),
strongyloidiasis,
ascariasis and
lymphatic filariasis. It works through many mechanisms to kill the targeted parasites and can be taken orally, or applied to the skin for external infestations.